Structured evidence table for Olive Leaf Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Olive Leaf Cholesterol Randomized Trial | The declining CVD mortality rate that was observed remained stable in the last years or even increased in some populations [,]. | 2 | Lauwers Stef (2026) | Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial |
| Olive Leaf Cholesterol Randomized Trial | 5 6 7 8 Poor management of factors, such as diet, physical activity, blood lipids, and blood pressure, will increase the risk of developing CVD as a 20 mmHg increase in systolic blood pressure (SBP) is associated with a doubled risk of death from CVD [,]. | 2 | Lauwers Stef (2026) | Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial |
| Olive Leaf Cholesterol Randomized Trial | CVD risk factors often occur clustered, as hypertension is linked to dyslipidaemia, impaired glucose tolerance and type 2 diabetes [,]. | 2 | Lauwers Stef (2026) | Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial |
| Olive Leaf Cholesterol Randomized Trial | 1 2 3 4 Over the past few decades, remarkable progress has been made in developing strategies to lower the incidence of cardiovascular diseases (CVD). | 2 | Lauwers Stef (2026) | Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial |
| Olive Leaf Cholesterol Randomized Trial | Atherosclerosis is a chronic inflammatory cardiovascular disease that may result from the interaction between oxidative stress, immune dysregulation, and metabolic disorders. | 4 | Morvaridzadeh M (2025) | Polyphenol-Microbiota Interactions in Atherosclerosis: The Role of Hydroxytyrosol and Tyrosol in Modulating Inflammation and Oxidative Stress. |
| Olive Leaf Cholesterol Randomized Trial | A deeper understanding of these mechanisms could support the development of precision nutrition strategies aimed at reducing the risk of atherosclerosis. | 4 | Morvaridzadeh M (2025) | Polyphenol-Microbiota Interactions in Atherosclerosis: The Role of Hydroxytyrosol and Tyrosol in Modulating Inflammation and Oxidative Stress. |
| Olive Leaf Cholesterol Randomized Trial | Recent studies indicate that the well-known phenolic compounds, hydroxytyrosol (HTyr) and tyrosol (Tyr) present in extra virgin olive oil, confer cardioprotection through various mechanisms of action that include antioxidant, anti-inflammatory, and metabolic regulatory properties. | 4 | Morvaridzadeh M (2025) | Polyphenol-Microbiota Interactions in Atherosclerosis: The Role of Hydroxytyrosol and Tyrosol in Modulating Inflammation and Oxidative Stress. |
Source documents